DUKE STREET BIO
Duke Street Bio develops medical drugs intended to provide improved treatment to cancer patients. It was founded in 2020 and is based in London, England.
DUKE STREET BIO
Social Links:
Industry:
Biopharma Biotechnology Life Science Medical
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.dukestbio.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
AANDSA Pharm
AANDSA Pharm develop a controlled drug delivery hydrogel patch for psoriasis.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
PlantExt
PlantExt develops medical cannabis products intended to provide anti-inflammatory remedies.
Sentai
Sentain is learning for contextual conversation that provides timely alerts for the important things.
Thiakis
Thiakis develop novel analogues of naturally occurring hormones for the treatment of obesity and co-morbidities.
Wockhardt Bio AG
Wockhardt Bio develops, manufactures and markets pharmaceutical and bio-pharmaceutical formulations.
Current Employees Featured
Official Site Inspections
http://www.dukestbio.com
- Host name: 45.87.81.83
- IP address: 45.87.81.83
- Location: Republic of Lithuania
- Latitude: 56
- Longitude: 24
- Timezone: Europe/Vilnius
More informations about "Duke Street Bio"
About | Duke Street Bio - dukestbio.com
Duke Street Bio is focused on exploiting tumour genetic vulnerabilities by developing the next generation of molecules targeting DNA Damage Repair (DDR) deficiencies in cancer.See details»
Duke Street Bio | Pioneering Next Generation Cancer …
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.See details»
People | Duke Street Bio - dukestbio.com
Duke Street Bio has an experienced and proven management team with an exceptional track record of delivering clinical molecules across therapeutic areas.See details»
Duke Street Bio - LinkedIn
Duke Street Bio is focused on exploiting tumour genetic vulnerabilities and harnessing the natural power of the body’s immune system to fight cancer.See details»
Duke Street Bio - Crunchbase Company Profile
Duke Street Bio develops medical drugs intended to provide improved treatment to cancer patients.See details»
DUKE STREET BIO LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DUKE STREET BIO LIMITED of LONDON. Get the latest business insights from Dun & Bradstreet.See details»
DUKE STREET BIO EBT LIMITED - Dun & Bradstreet
Popular Search: Business, Professional, Labor, Political, and Similar OrganizationsReligious, Grantmaking, Civic, Professional, and Similar OrganizationsOther Services (except Public …See details»
Duke Street Bio - 2025 Company Profile & Competitors - Tracxn
Mar 22, 2025 Duke Street Bio - Developer of precision medicine-based cancer therapies. Founded by Barry McGuinness and Phill Cowley in the year 2019. Duke Street Bio has 646 …See details»
Duke Street Bio News - dukestbio.com
May 22, 2022 Duke Street Bio Ltd, a precision medicine biotech developing next generation small molecule cancer therapies, is pleased to announce that the European Medicines Agency (EMA) has granted approval to commence a …See details»
Duke Street Bio - VentureRadar
"Duke Street Bio is focused on reprogramming cancer cell and tumour microenvironment biology to unleash the natural power of the body’s immune system to fight cancer. We are using …See details»
Duke Street Bio 2025 Company Profile: Valuation, Funding
Sep 9, 2020 Information on valuation, funding, cap tables, investors, and executives for Duke Street Bio. Use the PitchBook Platform to explore the full profile.See details»
Duke Street Bio | Startup Profile and Investments - Bounce Watch
Duke Street Bio is a biopharmaceutical and biotechnology company based in the United Kingdom. Founded in 2020, the company is committed to pioneering next-generation cancer therapies. …See details»
Duke Street Bio enters stage with next-generation cancer therapies
May 25, 2022 The UK startup Duke Street Bio has exited stealth mode with funding to develop PARP enzyme inhibitors that treat cancer by blocking the repair of DNA in tumor cells.See details»
Duke Street Bio | VentureRadar
Duke Street Bio is focused on reprogramming cancer cell and tumour microenvironment biology to unleash the natural power of the body’s immune system to fight cancer. We are using cutting …See details»
Duke Street Bio granted approval by European Medicines Agency …
We believe that DSB2455 has the potential for improved efficacy and tolerability versus first-generation PARP inhibitors in patient populations where there is still significant unmet medical …See details»
Duke Street Bio - EU-Startups
Duke Street Bio develops medical drugs intended to provide improved treatment to cancer patients. Duke Street Bio is focused on reprogramming cancer cell and tumour …See details»
Contact | Duke Street Bio - dukestbio.com
Send Us a Message© Duke Street Bio Ltd | [email protected] | PrivacySee details»
dukestbio.com Reviews | check if site is scam or legit| Scamadviser
Check dukestbio.com with our free review tool and find out if dukestbio.com is legit and reliable. Need advice? Report scams Check Scamadviser!See details»
Pipeline | Duke Street Bio - dukestbio.com
Duke Street Bio’s differentiated small molecule pipeline targets enzymes controlling DDR and the anti-tumour immune responseSee details»
Publications | Duke Street Bio - dukestbio.com
Cowley, et al Profiling of PARP1-selective inhibitor DSB2455 in HR deficient and proficient cancer models as monotherapy and in combination EORTC-NCI-AACR Symposium 2024 View PosterSee details»